Cytochrome P-450 (CYP) enzymes are crucial for drug metabolism, cholesterol, and lipid biosynthesis, primarily in the liver, but also in other tissues. Drug interactions involving CYP enzymes can lead to altered drug effectiveness or toxicity through mechanisms of enzyme inhibition and induction, where one drug affects the metabolism of another. Inhibition can occur in several ways, including competitive or non-competitive mechanisms, while induction by certain drugs or pollutants can enhance the metabolism of other substrates.